Abstract
The author has investigated the bowel-sterilizing powers of framycetin sulphate, and has compared its potency with that of neomycin. He has found that the drug is well tolerated, and not toxic in doses which are sufficient to suppress faecal organisms satisfactorily.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BURROWS D. Framycetin sulphate: a cutaneous antibiotic. Br Med J. 1958 Aug 16;2(5093):428–429. doi: 10.1136/bmj.2.5093.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CONNELL J. F., Jr, ROUSSELOT L. M. Preliminary studies on a new intestinal bactericide; soframycin. Surgery. 1958 Sep;44(3):447–452. [PubMed] [Google Scholar]
- DECARIS L. J. Un Streptomyces lavendulae, producteur d'un nouvel antibiotique. Ann Pharm Fr. 1953 Jan;11(1):44–46. [PubMed] [Google Scholar]
- FAIRBROTHER R. W., WILLIAMS B. L. In-vitro activity of ristocetin and framycetin; two new antibiotics. Lancet. 1958 Dec 27;2(7061):1353–1355. doi: 10.1016/s0140-6736(58)91440-5. [DOI] [PubMed] [Google Scholar]
- LOUWETTE R., LAMBRECHTS A. Framycetin in infantile gastroenteritis due to pathogenic Escherichia coli. Br Med J. 1958 Apr 12;1(5075):868–869. doi: 10.1136/bmj.1.5075.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MACCABE A. F. Current therapeutics. CXXXVII. Framycetin. Practitioner. 1959 May;182(1091):628–634. [PubMed] [Google Scholar]
- MARMELL M., PRIGOT A., SHIDLOVSKY B. A. Preliminary report on bowel sterilization with soframycin. Antibiot Annu. 1955;3:118–121. [PubMed] [Google Scholar]